One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Endoscopy Devices Global Market

内視鏡装置グローバル市場ー業界洞察、主要プレーヤー・企業別、成長機会別、最新傾向別、開発別、主要な成長ドライバー別、主要な課題別によってセグメンテーション、予測 2028年


[ 英語タイトル ] Endoscopy Devices Global Market - Forecast To 2028


Product Code : IQ4IHC00116243
Survey : IQ4I
Publish On : December, 2021
Category : Healthcare and Pharmaceuticals
Study Area : North America (U.S. and Others), Europe (Germany, France, U.K. and Others), Asia-Pacific (Japan, China, India, and Others), Rest of World (Brazil, Rest of Latin America, Middle East & Others)
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4950 / Question Form
5 User USD6750 / Question Form
Enterprise User USD9000 / Question Form
ARTHREX, INC.
B. BRAUN MELSUNGEN AG
BOSTON SCIENTIFIC CORPORATION
FUJIFILM HOLDINGS CORPORATION
HOYA CORPORATION (PENTAX MEDICAL)
JOHNSON & JOHNSON
KARL STORZ SE & CO. KG
MEDTRONIC PLC
OLYMPUS CORPORATION
STRYKER CORPORATION
LIST OF COMPANIES MENTIONED IN THE REPORT
3NT MEDICAL LTD.
ACE MEDICAL DEVICES PVT. LTD.
ACKERMANN INSTRUMENTE GMBH
ACTEON GROUP (COMEG MEDICAL TECHNOLOGIES)
ADEOR MEDICAL AG
ALLTION CO., LTD.
AMBU A/S
AMERICAN MEDICAL ENDOSCOPY
ANIKA THERAPEUTICS, INC.
ANX ROBOTICA CORPORATION
AOHUA ENDOSCOPE CO. LTD.
ARTHREX, INC.
B.BRAUN MELSUNGEN AG
BIOP MEDICAL
BOLTON SURGICAL LIMITED
BOSTON SCIENTIFIC CORPORATION
BRIDGEMASTER MEDICAL
BRITEMED TECHNOLOGY INC.
"CANADY LIFE SCIENCES (ENDOCONTROL SA)
"
CHONGQING JINSHAN SCIENCE & TECHNOLOGY (GROUP) CO., LTD
CONMED CORPORATION
CONTACT CO. LLC.
COOK GROUP
COOPERSURGICAL, INC.
COSMO PHARMACEUTICALS NV
DEWIMED MEDIZINTECHNIK GMBH (REMA MEDIZINTECHNIK GMBH)
EFER ENDOSCOPY
EIZO CORPORATION
ELECTRO MEDICAL SYSTEMS
EMOS TECHNOLOGY GMBH
ENDO INDONESIA, PT
ENDOLOOK (ENDOSERVICE GMBH)
ENDOMASTER PTE. LTD.
ERA ENDOSCOPY SRL
ERBE ELEKTROMEDIZIN GMBH
EVOENDO INC.
FANNIN LTD.
FIREFLY GLOBAL
FRANKENMAN INTERNATIONAL, LTD
FUJIFILM HOLDINGS CORPORATION
GI VIEW LTD.
GIMMI GMBH
GULF FIBEROPTICS GROUP
HAPPERSBERG OTOPRONT GMBH
HEINE OPTOTECHNIK GMBH & CO. KG
HILL-ROM SERVICES, INC.
HOBBS MEDICAL, INC
HOLOGIC, INC.
HOOGLAND SPINE PRODUCTS GMBH
HOYA CORPORATION
HUNAN VATHIN MEDICAL INSTRUMENT CO., LTD.
ILO ELECTRONIC, GMBH
INKA SURGICAL INSTRUMENTS
INTEGRATED ENDOSCOPY
INTROMEDIC
INTUITIVE SURGICAL, INC.
JIANGSU BRIGHTNESS MEDICAL DEVICE CO., LTD.
JINSHAN SCIENCE & TECHNOLOGY (GROUP) CO., LTD.
JOHNSON & JOHNSON
JOIMAX GMBH
KARL STORZ SE CO. & KG
LABORIE (COGENTIX MEDICAL)
LAGIS ENTERPRISE CO., LTD
LAPROSURGE, LTD
LEMAITRE VASCULAR, INC.
LINA MEDICAL
LOCAMED LTD
MACHIDA ENDOSCOPE CO. LTD
MEDGYN PRODUCT, INC
MEDICON
MEDIFLEX SURGICAL
MEDIGUS LTD.
MEDIT INC.
MEDROBOTICS CORPORATION
MEDTRONIC, PLC
MERIT MEDICAL SYSTEMS INC.
MICROSOFT CORPORATION
MOBILE ODT
NEC CORPORATION
NOVANTA INC. (NDS SURGICAL IMAGING)
NOVAPROBE INC.
OLYMPUS CORPORATION
OM SURGICALS
OMNIVISION TECHNOLOGIES, INC.
OPHIT CO.LTD.
OPTOMIC
ORAVU
ORPHEUS-MEDICAL LTD
OVESCO ENDOSCOPY AG
PALLIARE LTD.
PARBURCH MEDICAL
PERIOENDOSCOPY LLC
PROSURG INC.
PROVIX
PURPLE SURGICAL INTERNATIONAL LTD.
RICHARD WOLF GMBH
ROCKET MEDICAL PLC
ROPER TECHNOLOGIES INC. (VERATHON INC.)
RUDOLF MEDICAL GMBH & CO. KG.
SCHINDLER ENDOSKOPIE TECHNOLOGIE GMBH
SCHOLLY FIBEROPTIC GMBH
SCHOTT AG
SHANGHAI MICROPORT MEDICAL CO., LTD
SHENYANG SHENDA ENDOSCOPE CO. LTD.
SKLAR SURGICAL INSTRUMENTS
SMART MEDICAL SYSTEMS LTD.
SMITH & NEPHEW PLC
SOLOS ENDOSCOPY
SONOSCAPE MEDICAL CORP.
STERIS CORPORATION
STRYKER CORPORATION
TEKNO-MEDICAL OPTIK-CHIRURGIC GMBH
TIMESCO
TRICE MEDICAL
UNIVLABS TECHNOLOGIES PVT LTD
UROVIU CORPORATION
UTAH MEDICAL (FEMCARE-NIKOMED)
UVISION360
VIMEX ENDOSCOPY
VISIONSCOPE TECHNOLOGIES, LLC
W.O.M. WORLD OF MEDICINE GMBH
WISAP MEDICAL TECHNOLOGY
XENOCOR INC.
XION GMBH
ZEST DENTAL SOLUTIONS
ZUMAX MEDICAL MEDICAL CO. LTD.

[Report Description]

Endoscopy is a minimally invasive or non-invasive medical procedure that utilizes specialized devices like endoscopes for the detailed inspection or assessment, and manipulation or treatment of diseased organs or tissues by visualizing the internal organ or area of interest. The constantly advancing various emergency or elective endoscopy procedures are being used for the timely diagnosis, and minimally-traumatic treatment of various chronic ailments like cancer, arthritis, joint injuries, inflammatory bowel diseases (IBD), chronic pancreatitis, obesity, Barrett’s esophagus, and others.
As estimated by IQ4I analysis, the endoscopy devices global market is expected to reach $39,475.6 million by 2028 growing at a high single digit CAGR from 2021 to 2028 due to persistently escalating prevalence, and incidence of chronic diseases across the globe, and the need for early diagnostic, and therapeutic interventions, increasing inclination of patients towards the minimally invasive therapeutic procedures, gradual transition of endoscopy devices market towards single-use endoscopes, the emergence of technologically advanced endoscopy products, the trend of acquisitions, and collaborations in the endoscopy device industry, and the increasing awareness, and adoption of the highly beneficial endoscopic procedures across the emerging nations.
The endoscopy devices global market is categorized into various market segments based on the product, application, end-users, and geography. Based on the type of endoscopy products, the market is segmented into endoscopes, endoscopic instruments, and endoscopic accessories. Among these, the Endoscopic Instruments segment held the largest share in 2021, and is expected to grow at a mid single digit CAGR from 2021 to 2028 due to the increasing popularity of image-guided endoscopic surveillance, diagnostic, and therapeutic procedures to reduce morbidity, and mortality associated with the highly prevalent chronic diseases across the globe, and the necessity of the various endoscopy instruments to ensure the efficiency, safety, and completeness of an endoscopy procedure. Endoscopes segment is the fastest emerging segment growing at a high single digit CAGR from 2021 to 2028 due to the escalating demand for timely, and precise minimally invasive or non-invasive diagnostic, and therapeutic procedures from the large chronic disease patient pool across the globe, various technological, and fabrication advancements in endoscopes that are constantly expanding their diagnostic, and therapeutic application spectrum. Based on the product type, endoscopes have been further segmented into flexible endoscopes, rigid endoscopes, robot-assisted endoscopes, and AI-enhanced endoscopes, and capsule endoscopes. Among these, the Rigid Endoscopes segment occupy a major share in 2021 and is expected to grow at a high single digit CAGR from 2021 to 2028 due to increased utilization of rigid endoscopes for performing the highly popular endoscopic diagnostic, and therapeutic procedures like laparoscopy, arthroscopy, ENT endoscopy, and neuroendoscopy procedures, and the potential of rigid endoscopes to offer the best resolution, optical amplification, and larger field of view to perform various endoscopic procedures efficiently, and safely. Robot-Assisted Endoscopes, and artificial intelligence (AI) powered endoscopes segment is expected to be the fastest emerging segment growing with a double digit CAGR from 2021 to 2028 due to the emergence of several Robot Assisted Endoscopes, and AI guided endoscopy systems in the market, and the promising potential of robot-assisted endoscopes, and AI-enhanced endoscopy systems to mitigate the labor intensity of endoscopic procedures, and increase the precision, and safety of endoscopic procedures. Endoscopic instruments are further grouped into endoscopic cameras, digital documentation systems, light sources, monitors, and display systems, video converters, and processors, fluid management systems, and other endoscopic instruments comprised of insufflators, endoscopic ultrasound probes, and processors. Among the various endoscopic instruments, the Monitors, and display systems segment occupies a major share of revenue in 2021, and is expected to grow at a mid single digit CAGR from 2021 to 2028 due to the increasing utilization of highly accurate, and real-time images or videos to arrive at the optimum or error-free diagnostic conclusions, and to provide better clarity of the complex anatomical details to improve the precision, task efficiency, and productivity of surgeons during endoscopic therapeutic procedures, availability of technologically advanced monitors, and display units, and increasing popularity of image-guided minimally invasive endoscopic diagnostic, and therapeutic interventions among the masses. The digital documentation systems segment is expected to be the fastest-growing segment growing with a high single digit CAGR from 2021 to 2028 due to the increasing recognition of the importance of endoscopic image documentation or recording process as an integral aspect of endoscopy procedures to ensure the quality, safety, productivity, completeness, and efficiency of endoscopic procedures, and the various guidelines of major endoscopic societies like European Society of Gastrointestinal Endoscopy (ESGE), and American Society of Gastrointestinal Endoscopy (ASGE) that recommend systematic photo recording or documentation of endoscopy procedures, the necessity of digitalized documents to address or satisfy the concerns of the insurance providers, legal institutions, patients, and hospital trusts, and need of digital documents to guide future therapeutic decisions, and persistent technological advancements in the digital documentation systems. Endoscopic accessories are further classified into product types like biopsy forceps, graspers, snares, Trocars, surgical dissectors, and other accessories like endoscopic ultrasound needles, light cables, cytology brushes, bite-blocks, cleaning brushes, needle holders, retractors, endoscopic caps, and hoods, endoscopy masks. Among the various endoscopic accessories, the trocars segment occupy the largest share of revenue in 2021, and is the fastest emerging segment growing at a high single digit CAGR from 2021 to 2028 due to the necessity of the channel created by a trocar for the safer advancement or passage of endoscopes, and other equipment to internal body cavities through the smaller incisions with low insertion force, and without tearing, scarring or ripping off the surrounding fragile tissues or organs during endoscopy procedures.
The global endoscopy devices market based on applications has been classified into Arthroscopy, Pulmonary endoscopy, Laparoscopy, ENT endoscopy, Gastrointestinal endoscopy, Gynecology or obstetrics endoscopy, Neuroendoscopy, Urological endoscopy, and other Endoscopic applications consisting of cardiopulmonary endoscopy, dental endoscopy, ophthalmology endoscopy, and breast endoscopy. Among these, the Gastrointestinal endoscopy segment occupied the largest market share in 2021, and is expected to grow at a mid single digit CAGR from 2021 to 2028 due to the persistently increasing prevalence of chronic diseases of the digestive tract, and the potential of gastrointestinal endoscopy to provide accurate diagnostic, and therapeutic solutions, increasing popularity of endoscopic surveillance as a preventive strategy for gastrointestinal cancer-associated morbidity, and mortality, and the ever-expanding diagnostic, and therapeutic application spectrum of gastrointestinal endoscopy procedures. The laparoscopy segment is the fastest emerging segment growing at a double digit CAGR from 2021 to 2028 due to the steadily escalating prevalence of chronic diseases of the digestive system, female reproductive system, and urinary tract system, and the potential of laparoscopy to provide accurate diagnostic, and therapeutic solutions, and the increasing research, and development activities leading to the emergence of numerous technologically advanced, patient-friendly, cosmetically advantageous laparoscopic procedures. The arthroscopy market is further segmented into knee arthroscopy, shoulder arthroscopy, wrist arthroscopy, ankle arthroscopy, elbow arthroscopy, hip arthroscopy, and other arthroscopy procedures consisting of spinal arthroscopy, and temporomandibular joint arthroscopy. Among these, the knee arthroscopy segment accounted for the largest revenue in 2021, and is expected to grow at a double digit CAGR from 2021 to 2028 due to the persistently elevating prevalence of knee joint injuries especially related to sports, and increasing adoption of arthroscopy to provide premium diagnostic, and accurate therapeutic solutions. The hip arthroscopy segment is the fastest emerging segment growing at a double digit CAGR during the forecasted period due to the ever-escalating prevalence of hip injuries associated with sports or accidents, increasing popularity of hip arthroscopy procedures across the globe, and the increasing research focus for the development of more efficient, and safer hip arthroscopy products. The pulmonary endoscopy market is further classified into bronchoscopy, thoracoscopy, and mediastinoscopy. Among these, the bronchoscopy segment accounted for the largest revenue in 2021, and is the fastest emerging segment growing at a mid single digit CAGR from 2021 to 2028 due to the persistently escalating prevalence of chronic diseases of the lungs or bronchi, increasing utilization of bronchoscopy to provide premium diagnostic, and accurate therapeutic solutions, the ever-expanding diagnostic, and therapeutic spectrum of bronchoscopy, and the increasing research focus for the development of more efficient, and safer bronchoscopy products. The ENT endoscopy market is further categorized into nasal endoscopy, laryngoscopy, otoendoscopy, and transnasal endoscopy procedures. Among these, the nasal endoscopy segment accounted for the largest revenue in 2021, and is expected to grow at a mid single digit CAGR from 2021 to 2028 due to the constantly escalating prevalence of chronic diseases associated with nasal cavity, and sinus passages, and increasing adoption of nasal endoscopy to provide optimum diagnostic, and therapeutic solutions. The laryngoscopy segment is the fastest emerging segment growing at a mid single digit CAGR from 2021 to 2028 due to the ever elevating prevalence of chronic diseases associated with throat, larynx, and salivary gland, increasing popularity of laryngoscopy procedures across the globe, and the increasing research focus for the development of more efficient, and laryngoscopy products. The gastrointestinal endoscopy market is further segmented into Esophagogastroduodenoscopy, enteroscopy, colonoscopy, sigmoidoscopy, proctoscopy, and Cholangiopancreatoscopy procedures. Among these, the esophagogastroduodenoscopy segment accounted for the largest revenue in 2021, and is expected to grow at a mid single digit CAGR during the forecasted period due to the persistently escalating chronic diseases affecting the esophagus, stomach, duodenum, increasing adoption of esophagogastroduodenoscopy to provide optimized, and timely diagnostic, and therapeutic solutions, and the emergence of more efficient, and safer technologically advanced esophagogastroduodenoscopy products. The colonoscopy segment is the fastest emerging segment growing at a high single digit CAGR from 2021 to 2028 due to the ever-increasing prevalence of chronic diseases of the colon, and rectum, increasing adoption, and implementation of colonoscopic surveillance as a preventive strategy for colorectal cancer-associated morbidity, and mortality across the globe, and the increasing research focus for the development of more efficient, and colonoscopy products. The gynecological/obstetrics endoscopy market is further classified into Hysteroscopy, Colposcopy, Falloposcopy, and others comprised of amnioscopy, and fetoscopy procedures. Among these, the hysteroscopy segment accounted for the largest revenue in 2021, and is the fastest emerging segment growing at a mid single digit CAGR from 2021 to 2028 due to the steadily escalating prevalence of endocervical or intrauterine diseases, increasing utilization of hysteroscopy to provide precise diagnostic, and therapeutic solutions, the ever-expanding diagnostic, and therapeutic spectrum of hysteroscopy, and the increasing research focus for the development of more efficient, and safer hysteroscopy products. The neuroendoscopy market is further subdivided into epiduroscopy or spinal endoscopy, Intraventricular neuroendoscopy, Transcranial neuroendoscopy, and Transnasal neuroendoscopy procedures. Among these, the intraventricular neuroendoscopy segment accounted for the largest revenue in 2021, and is expected to grow at a mid single digit CAGR from 2021 to 2028 due to the persistently elevating prevalence of ventricular system associated diseases, and increasing adoption of intraventricular neuroendoscopy to provide accurate diagnostic, and accurate therapeutic solutions. The transcranial neuroendoscopy segment is the fastest emerging segment growing at a high single digit CAGR during the forecasted period due to the ever-escalating prevalence of anterior skull base region associated diseases, increasing popularity of transcranial neuroendoscopy procedures across the globe, and the increasing research focus for the development of more efficient, and safer transcranial neuroendoscopy products. The urological endoscopy market is further categorized into Nephroscopy, Cystoscopy, ureteroscopy, and resectoscopy procedures. Among these, the ureteroscopy segment accounted for the largest revenue in 2021, and is the fastest emerging segment growing at a high single digit CAGR from 2021 to 2028 due to the constantly elevating prevalence of chronic diseases associated with ureters, and kidney, increasing utilization of ureteroscopy to provide unerring diagnostic, and therapeutic solutions, the ever-expanding diagnostic, and therapeutic spectrum of ureteroscopy, and the increasing research focus for the development of more efficient, and safer ureteroscopy products. Laparoscopic procedures are further classified into laparoscopic bariatric surgery, cholecystectomy, appendectomy, hernia repair, and hand-assisted laparoscopic procedures. Among these, the laparoscopic cholecystectomy segment accounted for the largest revenue in 2021, and is expected to grow at a double digit CAGR from 2021 to 2028 due to the persistently elevating prevalence of gall bladder disorders, and increasing adoption of laparoscopic cholecystectomy to provide explicit diagnostic, and therapeutic solutions. The laparoscopic bariatric surgery segment is the fastest emerging segment growing at a double digit CAGR during the forecasted period due to the ever-escalating prevalence of obesity across the globe, increasing popularity of laparoscopic bariatric surgery across the globe, and the increasing research focus for the development of more efficient, and safer laparoscopic bariatric surgery products.
Based on the end-users, the endoscopy devices global market has been segmented into Hospitals, Endoscopy Ambulatory surgery centers (EASCs), Endoscopy Diagnostic Centers, and others consisting of Academic or Research Institutes, and Office based Endoscopy (OBE) suites. Among the various end-users, the Hospitals segment is the largest, and fastest emerging end-user and is expected to grow at a high single digit CAGR during the forecasted period due to the increased utilization of advanced endoscopy products in these clinical settings, the presence of a large number of sophisticated hospitals in the developed nations, and the constantly increasing number of hospitals with advanced infrastructural facilities in the developing nations.
The endoscopy devices global market is divided into four major geographies namely, North America, Europe, Asia Pacific (APAC), and the Rest of the World (ROW). Among these, North America occupied the largest share in the 2021 endoscopy devices global market, and is expected to grow at a mid single digit CAGR during the forecasted period. Persistently elevating chronic disease patient burden in the region, and elevating demand for the early diagnosis, and treatment of these diseases, escalating geriatric population burdened with numerous kinds of chronic diseases in the region, the increasing inclination, and adoption of technologically advanced diagnostic procedures, and minimally invasive therapeutic procedures by the patients of the region, availability of well-developed healthcare infrastructural facilities in the region, presence of several major endoscopy device companies in the region, and their increasing R&D investments in the region for the development of innovative, efficient, and safer endoscopy products, and a conducive regulatory, and reimbursement scenario in the region promoting the adoption of single-use endoscopes in the region are some of the factors that are propelling the endoscopy devices market growth in the region. Asia-Pacific region is the fastest emerging region and is expected of growing at a high single digit CAGR from 2021 to 2028. Steadily escalating chronic disease patient population in the region, and increasing demand for the prompt diagnosis, and treatment of these diseases, elevating geriatric population crippled with numerous kinds of chronic diseases in the region, increasing awareness, and demand for technologically advanced diagnostic procedures, and minimally invasive therapeutic procedures by the patients of the region, developing healthcare infrastructural facilities in the region, medical tourism prospects of some of the countries in the region, presence of several major endoscopy device companies in the region, and their increasing R&D investments for the development of innovative, efficient, and safer endoscopy products, presence of several domestic companies in the region offering endoscopy products at competitive prices, growing economies, and improving reimbursement scenario of these regions are some of the factors that are boosting the endoscopy devices market in the region
The endoscopy devices global market is a competitive market with more than half of the market being occupied by the top six players. Some of the key players of the endoscopy devices market are Olympus Corporation (Japan), Boston Scientific Corporation (U.S.), Stryker Corporation (U.S.), Karl Storz SE & Co KG (Germany), Johnson & Johnson (U.S.), and Medtronic PLC (Ireland), Arthrex Inc. (U.S.), B. Braun Melsungen AG (Germany), Fujifilm Holdings Corporation (Japan), Hoya Corporation (Japan), and other Arthrex Inc. (U.S.), B. Braun Melsungen AG (Germany), Fujifilm Holdings Corporation (Japan), Hoya Corporation (Japan), and others.
The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
• North America
o U.S.
o Rest of North America
• Europe
o Germany
o France
o U.K.
o Rest of Europe
• Asia-Pacific
o China
o Japan
o India
o Rest of APAC
• Rest of the World (ROW)
o Brazil
o Rest of LATAM
o The Middle East and Others


1 EXECUTIVE SUMMARY 33
2 INTRODUCTION 44
2.1 KEY TAKEAWAYS 44
2.2 SCOPE OF THE REPORT 45
2.3 REPORT DESCRIPTION 45
2.4 MARKETS COVERED 52
2.5 STAKEHOLDERS 56
2.6 RESEARCH METHODOLOGY 56
2.6.1 MARKET SIZE ESTIMATION 58
2.6.2 MARKET BREAKDOWN, AND DATA TRIANGULATION 61
2.6.3 SECONDARY SOURCES 62
2.6.4 PRIMARY SOURCES 62
2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES 63
2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES 64
2.6.7 ASSUMPTIONS 64
3 MARKET ANALYSIS 66
3.1 INTRODUCTION 66
3.2 MARKET SEGMENTATION 67
3.3 FACTORS INFLUENCING MARKET 71
3.3.1 DRIVERS, AND OPPORTUNITIES 72
3.3.1.1 Persistently escalating incidence, and prevalence of chronic
diseases and the need for early diagnosis, and treatment 72
3.3.1.2 Increasing inclination towards minimally invasive therapeutic
procedures 74
3.3.1.3 The gradual endoscopy market conversion from reusable
to single-use endoscopes 75
3.3.1.4 The emergence of technologically advanced endoscopy products 78
3.3.1.5 Persistently elevating geriatric population with chronic diseases 81
3.3.1.6 Acquisitions and collaborations to open an array of opportunities
for the market to flourish 82
3.3.1.7 Market expansion opportunities in emerging nations 83
3.3.2 RESTRAINTS, AND THREATS 85
3.3.2.1 High cost of the endoscopy devices, and procedures 85
3.3.2.2 Lack of skilled, and trained professionals 86
3.3.2.3 Increasing concerns about the adverse effects associated with
endoscopic procedures 88
3.3.2.4 Stringent regulatory bodies guiding the endoscopy device
manufacturers 89
3.3.2.5 The threat of non-invasive diagnostic, and therapeutic technologies 91
3.3.2.6 Unfavorable reimbursement scenario for the endoscopy procedures 92
3.4 REGULATORY AFFAIRS 93
3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION 94
3.4.1.1 ISO 9001: 2015 Quality Management System 94
3.4.1.2 ISO 13485 Medical Devices 94
3.4.1.3 ISO 10993 Biological Evaluation Of Medical Devices 95
3.4.2 THE U.S. 95
3.4.3 CANADA 97
3.4.4 EUROPE 98
3.4.5 JAPAN 99
3.4.6 CHINA 100
3.4.7 INDIA 102
3.5 REIMBURSEMENT SCENARIO 105
3.5.1 REIMBURSEMENT TABLE 109
3.6 TECHNOLOGICAL ADVANCEMENTS 133
3.6.1 THERAPEUTIC CAPSULE ENDOSCOPES WITH ACTIVE LOCOMOTION 133
3.6.2 MOLECULAR ENDOSCOPIC IMAGING (MEI) 134
3.6.3 VARIABLE STIFFNESS ENDOSCOPES, AND SHAPE LOCKING DEVICES OR OVERTUBES 135
3.6.4 MINIATURIZED ENDOSCOPES 135
3.6.5 3D ENDOSCOPES 135
3.6.6 NOTES, AND LESS 136
3.6.7 ADVANCED DIAGNOSTIC IMAGING TECHNIQUES 136
3.7 CLINICAL TRIALS 136
3.8 ENDOSCOPES – FDA, AND CE REGULATORY APPROVAL ANALYSIS 138
3.9 PATENT ANALYSIS 146
3.10 SINGLE-USE ENDOSCOPES MARKET 148
3.11 AUTOMATED ENDOSCOPE REPROCESSORS (AER) MARKET 156
3.12 REFURBISHED ENDOSCOPY DEVICES MARKET 159
3.13 PORTER’S FIVE FORCE ANALYSIS 162
3.13.1 THREAT OF NEW ENTRANTS 163
3.13.2 THREAT OF SUBSTITUTES 166
3.13.3 BARGAINING POWER OF SUPPLIERS 168
3.13.4 BARGAINING POWER OF BUYERS 169
3.13.5 COMPETITIVE RIVALRY 170
3.14 SUPPLY CHAIN ANALYSIS 172
3.15 AVERAGE SELLING PRICE (ASP) OF SELECT ENDOSCOPY DEVICES 182
3.16 IMPACT OF COVID-19 ON ENDOSCOPY DEVICES INDUSTRY 187
3.17 MARKET SHARE ANALYSIS 189
3.17.1 ENDOSCOPY DEVICES GLOBAL MARKET SHARE
BY KEY PLAYERS (2021) 189
3.17.2 ARTHROSCOPY DEVICES GLOBAL MARKET SHARE
BY KEY PLAYERS (2021) 194
3.17.3 PULMONARY ENDOSCOPY DEVICES GLOBAL MARKET SHARE
BY KEY PLAYERS (2021) 197
3.17.4 LAPARPOSCOPY DEVICES GLOBAL MARKET SHARE
BY KEY PLAYERS (2021) 201
3.17.5 UROLOGICAL ENDOSCOPY DEVICES GLOBAL MARKET SHARE
BY KEY PLAYERS (2021) 204
3.17.6 ENT ENDOSCOPY DEVICES GLOBAL MARKET SHARE
BY KEY PLAYERS (2021) 207
3.17.7 GASTROINTESTINAL ENDOSCOPY DEVICES GLOBAL MARKET SHARE
BY KEY PLAYERS (2021) 210
3.17.8 GYNECOLOGY ENDOSCOPY DEVICES GLOBAL MARKET SHARE
BY KEY PLAYERS (2021) 214
3.17.9 NEUROENDOSCOPY DEVICES GLOBAL MARKET SHARE
BY KEY PLAYERS (2021) 217
3.18 ENDOSCOPY DEVICES COMPANY COMPARISON TABLE
BY REVENUE, PRODUCT, PRODUCT TYPE, AND APPLICATION 219
4 ENDOSCOPY DEVICES GLOBAL MARKET, BY APPLICATIONS 233
4.1 INTRODUCTION 233
4.2 ARTHROSCOPY 237
4.2.1 INTRODUCTION 237
4.2.2 KNEE ARTHROSCOPY 241
4.2.3 SHOULDER ARTHROSCOPY 244
4.2.4 WRIST ARTHROSCOPY 247
4.2.5 ANKLE ARTHROSCOPY 250
4.2.6 ELBOW ARTHROSCOPY 252
4.2.7 HIP ARTHROSCOPY 254
4.2.8 OTHER ARTHROSCOPY PROCEDURES 258
4.3 PULMONARY ENDOSCOPY 261
4.3.1 INTRODUCTION 261
4.3.2 BRONCHOSCOPY 265
4.3.3 THORACOSCOPY 269
4.3.4 MEDIASTINOSCOPY 272
4.4 ENT ENDOSCOPY 275
4.4.1 INTRODUCTION 275
4.4.2 NASAL ENDOSCOPY 280
4.4.3 LARYNGOSCOPY 284
4.4.4 OTOENDOSCOPY 288
4.4.5 TRANSNASAL ENDOSCOPY 290
4.5 GASTROINTESTINAL ENDOSCOPY 293
4.5.1 INTRODUCTION 293
4.5.2 ESOPHAGOGASTRODUODENOSCOPY 299
4.5.3 ENTEROSCOPY 303
4.5.4 COLONOSCOPY 308
4.5.5 SIGMOIDOSCOPY 313
4.5.6 PROCTOSCOPY 317
4.5.7 CHOLANGIOPANCREATOSCOPY 320
4.6 GYNECOLOGY/OBSTETRICS 324
4.6.1 INTRODUCTION 324
4.6.2 HYSTEROSCOPY 329
4.6.3 COLPOSCOPY 333
4.6.4 FALLOPOSCOPY 336
4.6.5 OTHER GYNECOLOGY/OBSTETRICS ENDOSCOPY APPLICATIONS 339
4.7 NEUROENDOSCOPY 342
4.7.1 INTRODUCTION 342
4.7.2 EPIDUROSCOPY OR SPINAL ENDOSCOPY 346
4.7.3 INTRAVENTRICULAR NEUROENDOSCOPY 349
4.7.4 TRANSCRANIAL NEUROENDOSCOPY 351
4.7.5 TRANSNASAL NEUROENDOSCOPY 354
4.8 UROLOGICAL ENDOSCOPY 356
4.8.1 INTRODUCTION 356
4.8.2 NEPHROSCOPY 361
4.8.3 CYSTOSCOPY 364
4.8.4 URETEROSCOPY 367
4.8.5 RESECTOSCOPY 370
4.9 LAPAROSCOPY 373
4.9.1 INTRODUCTION 373
4.9.2 LAPAROSCOPIC BARIATRIC SURGERY 378
4.9.3 LAPAROSCOPIC CHOLECYSTECTOMY 381
4.9.4 LAPAROSCPIC APPENDECTOMY 383
4.9.5 LAPAROSCOPIC HERNIA REPAIR 385
4.9.6 HAND ASSISTED LAPAROSCOPY 388
4.10 OTHER ENDOSCOPY APPLICATIONS 390
5 ENDOSCOPY DEVICES GLOBAL MARKET, BY PRODUCTS 395
5.1 INTRODUCTION 395
5.2 ENDOSCOPES 398
5.2.1 RIGID ENDOSCOPES 403
5.2.2 FLEXIBLE ENDOSCOPES 406
5.2.3 ROBOT-ASSISTED ENDOSCOPES, AND AI ENHANCED ENDOSCOPES 412
5.2.4 CAPSULE ENDOSCOPES 420
5.3 ENDOSCOPIC INSTRUMENTS 426
5.3.1 INTRODUCTION 426
5.3.2 ENDOSCOPIC CAMERAS 431
5.3.3 DIGITAL DOCUMENTATION SYSTEMS 435
5.3.4 LIGHT SOURCES 438
5.3.5 MONITORS, AND DISPLAY SYSTEMS 441
5.3.6 VIDEO CONVERTERS, AND PROCESSORS 445
5.3.7 FLUID MANAGEMENT SYSTEMS 447
5.3.8 OTHER ENDOSCOPIC INSTRUMENTS (INSUFFLATORS, ULTRASOUND PROBES, AND PROCESSORS) 450
5.4 ENDOSCOPIC ACCESSORIES 454
5.4.1 BIOPSY FORCEPS 459
5.4.2 GRASPERS, AND RETRACTORS 463
5.4.3 SNARES 467
5.4.4 TROCARS 471
5.4.5 SURGICAL DISSECTORS 474
5.4.6 OTHER ENDOSCOPIC ACCESSORIES 476
6 ENDOSCOPY DEVICES GLOBAL MARKET, BY END-USERS 483
6.1 INTRODUCTION 483
6.2 HOSPITALS 486
6.3 ENDOSCOPY AMBULATORY SURGERY CENTERS (EASC) OR AMBULATORY ENDOSCOPY CENTERS (AEC) 490
6.4 ENDOSCOPY DIAGNOSTIC CENTERS 493
6.5 OTHER END-USERS (OFFICE BASED ENDOSCOPY (OBE) SUITES, AND ACADEMIC, AND RESEARCH INSTITUTES) 495
7 GLOBAL ENDOSCOPY PROCEDURAL VOLUME 499
7.1 ENDOSCOPY - NUMBER OF PROCEDURES BY REGION 499
7.1.1 GLOBAL ARTHROSCOPY PROCEDURAL VOLUME 499
7.1.2 GLOBAL GASTROINTESTINAL ENDOSCOPY PROCEDURAL VOLUME 500
7.1.3 GLOBAL COLONOSCOPY PROCEDURAL VOLUME 501
7.1.4 GLOBAL UROLOGICAL ENDOSCOPY PROCEDURAL VOLUME 503
7.1.5 GLOBAL LAPAROSCOPY PROCEDURAL VOLUME 504
7.1.6 GLOBAL ENT ENDOSCOPY ROCEDURAL VOLUME 505
7.1.7 GLOBAL PULMONARY ENDOSCOPY PROCEDURAL VOLUME 506
7.1.8 GLOBAL NEUROENDOSCOPY PROCEDURAL VOLUME 508
8 REGIONAL MARKET ANALYSIS 511
8.1 INTRODUCTION 511
8.2 NORTH AMERICA 515
8.2.1 U.S. 553
8.2.2 REST OF NORTH AMERICA 563
8.3 EUROPE 575
8.3.1 GERMANY 614
8.3.2 FRANCE 622
8.3.3 UNITED KINGDOM 628
8.3.4 REST OF EUROPE 636
8.4 ASIA-PACIFIC 644
8.4.1 JAPAN 681
8.4.2 CHINA 690
8.4.3 INDIA 699
8.4.4 REST OF ASIA-PACIFIC (APAC) 708
8.5 REST OF THE WORLD (ROW) 717
8.5.1 BRAZIL 754
8.5.2 REST OF LATAM 762
8.5.3 MIDDLE EAST & OTHERS 769
9 COMPETITIVE LANDSCAPE 778
9.1 INTRODUCTION 778
9.2 PRODUCT APPROVAL 780
9.3 PRODUCT LAUNCH 783
9.4 ACQUISITIONS 785
9.5 COLLABORATIONS 787
9.6 OTHER DEVELOPMENTS 788
10 MAJOR PLAYER PROFILES 792
10.1 ARTHREX, INC. 792
10.1.1 OVERVIEW 792
10.1.2 FINANCIALS 792
10.1.3 PRODUCT PORTFOLIO 793
10.1.4 KEY DEVELOPMENTS 797
10.1.5 BUSINESS STRATEGY 798
10.1.6 SWOT ANALYSIS 799
10.2 B. BRAUN MELSUNGEN AG 800
10.2.1 OVERVIEW 800
10.2.2 FINANCIALS 801
10.2.3 PRODUCT PORTFOLIO 803
10.2.4 KEY DEVELOPMENTS 806
10.2.5 BUSINESS STRATEGY 806
10.2.6 SWOT ANALYSIS 808
10.3 BOSTON SCIENTIFIC CORPORATION 809
10.3.1 OVERVIEW 809
10.3.2 FINANCIALS 810
10.3.3 PRODUCT PORTFOLIO 813
10.3.4 KEY DEVELOPMENTS 815
10.3.5 BUSINESS STRATEGY 816
10.3.6 SWOT ANALYSIS 818
10.4 FUJIFILM HOLDINGS CORPORATION 819
10.4.1 OVERVIEW 819
10.4.2 FINANCIALS 820
10.4.3 PRODUCT PORTFOLIO 822
10.4.4 KEY DEVELOPMENTS 826
10.4.5 BUSINESS STRATEGY 828
10.4.6 SWOT ANALYSIS 830
10.5 HOYA CORPORATION (PENTAX MEDICAL) 831
10.5.1 OVERVIEW 831
10.5.2 FINANCIALS 832
10.5.3 PRODUCT PORTFOLIO 834
10.5.4 KEY DEVELOPMENTS 839
10.5.5 BUSINESS STRATEGY 839
10.5.6 SWOT ANALYSIS 841
10.6 JOHNSON & JOHNSON 842
10.6.1 OVERVIEW 842
10.6.2 FINANCIALS 843
10.6.3 PRODUCT PORTFOLIO 846
10.6.4 KEY DEVELOPMENTS 849
10.6.5 BUSINESS STRATEGY 850
10.6.6 SWOT ANALYSIS 851
10.7 KARL STORZ SE & CO. KG 852
10.7.1 OVERVIEW 852
10.7.2 FINANCIALS 852
10.7.3 PRODUCT PORTFOLIO 853
10.7.4 KEY DEVELOPMENTS 860
10.7.5 BUSINESS STRATEGY 861
10.7.6 SWOT ANALYSIS 862
10.8 MEDTRONIC, PLC. 863
10.8.1 OVERVIEW 863
10.8.2 FINANCIALS 864
10.8.3 PRODUCT PORTFOLIO 868
10.8.4 KEY DEVELOPMENTS 872
10.8.5 BUSINESS STRATEGY 872
10.8.6 SWOT ANALYSIS 873
10.9 OLYMPUS CORPORATION 874
10.9.1 OVERVIEW 874
10.9.2 FINANCIALS 875
10.9.3 PRODUCT PORTFOLIO 878
10.9.4 KEY DEVELOPMENTS 888
10.9.5 BUSINESS STRATEGY 891
10.9.6 SWOT ANALYSIS 893
10.10 STRYKER CORPORATION 894
10.10.1 OVERVIEW 894
10.10.2 FINANCIALS 895
10.10.3 PRODUCT PORTFOLIO 898
10.10.4 KEY DEVELOPMENTS 901
10.10.5 BUSINESS STRATEGY 901
10.10.6 SWOT ANALYSIS 903

LIST OF TABLES
TABLE 1 ENDOSCOPY DEVICES GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 42
TABLE 2 ENDOSCOPY DEVICES GLOBAL MARKET REVENUE, BY APPLICATION
(2020-2028) ($MN) 235
TABLE 3 ARTHROSCOPY GLOBAL MARKET REVENUE, BY ANATOMY
(2020-2028) ($MN) 239
TABLE 4 ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION,
(2020-2028) ($MN) 241
TABLE 5 KNEE ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION,
(2020-2028) ($MN) 244
TABLE 6 SHOULDER ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 247
TABLE 7 WRIST ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 249
TABLE 8 ANKLE ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 251
TABLE 9 ELBOW ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 254
TABLE 10 HIP ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 257
TABLE 11 OTHER ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 260
TABLE 12 PULMONARY ENDOSCOPY GLOBAL MARKET REVENUE, BY ANATOMY
(2020-2028) ($MN) 263
TABLE 13 PULMONARY ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 265
TABLE 14 BRONCHOSCOPY GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 269
TABLE 15 THORACOSCOPY GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 272
TABLE 16 MEDIASTINOSCOPY GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 275
TABLE 17 ENT ENDOSCOPY GLOBAL MARKET REVENUE, BY ANATOMY
(2020-2028) ($MN) 278
TABLE 18 ENT ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 280
TABLE 19 NASAL ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 283
TABLE 20 LARYNGOSCOPY GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 287
TABLE 21 OTOENDOSCOPY GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 290
TABLE 22 TRANSNASAL ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 293
TABLE 23 GASTROINTESTINAL ENDOSCOPY GLOBAL MARKET REVENUE, BY ANATOMY (2020-2028) ($MN) 297
TABLE 24 GASTROINTESTINAL ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN) 299
TABLE 25 ESOPHAGOGASTRODUODENOSCOPY GLOBAL MARKET REVENUE,
BY REGION (2020-2028) ($MN) 303
TABLE 26 ENTEROSCOPY GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 307
TABLE 27 COLONOSCOPY GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 312
TABLE 28 SIGMOIDOSCOPY GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 316
TABLE 29 PROCTOSCOPY GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 320
TABLE 30 CHOLANGIOPANCREATOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN) 323
TABLE 31 GYNECOLOGY/OBSTETRICS ENDOSCOPY GLOBAL MARKET REVENUE,
BY ANATOMY (2020-2028) ($MN) 327
TABLE 32 GYNECOLOGY/OBSTETRICS ENDOSCOPY GLOBAL MARKET REVENUE,
BY REGION (2020-2028) ($MN) 329
TABLE 33 HYSTEROSCOPY GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 332
TABLE 34 COLPOSCOPY GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 336
TABLE 35 FALLOPOSCOPY GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 339
TABLE 36 OTHER GYNECOLOGY/OBSTETRICS ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN) 341
TABLE 37 NEUROENDOSCOPY GLOBAL MARKET REVENUE, BY ANATOMY
(2020-2028) ($MN) 344
TABLE 38 NEUROENDOSCOPY GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 346
TABLE 39 SPINAL ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 348
TABLE 40 INTRAVENTRICULAR NEUROENDOSCOPY GLOBAL MARKET REVENUE,
BY REGION (2020-2028) ($MN) 351
TABLE 41 TRANSCRANIAL NEUROENDOSCOPY GLOBAL MARKET REVENUE,
BY REGION (2020-2028) ($MN) 353
TABLE 42 TRANSNASAL NEUROENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN) 356
TABLE 43 UROLOGICAL ENDOSCOPY GLOBAL MARKET REVENUE, BY ANATOMY
(2020-2028) ($MN) 359
TABLE 44 UROLOGICAL ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 361
TABLE 45 NEPHROSCOPY GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 363
TABLE 46 CYSTOSCOPY GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 366
TABLE 47 URETEROSCOPY GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 369
TABLE 48 RESECTOSCOPY GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 372
TABLE 49 LAPAROSCOPY GLOBAL MARKET REVENUE, BY ANATOMY
(2020-2028) ($MN) 376
TABLE 50 LAPAROSCOPY GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 378
TABLE 51 LAPAROSCOPIC BARIATRIC SURGERY GLOBAL MARKET REVENUE,
BY REGION (2020-2028) ($MN) 380
TABLE 52 LAPAROSCOPIC CHOLECYSTECTOMY GLOBAL MARKET REVENUE,
BY REGION (2020-2028) ($MN) 383
TABLE 53 LAPAROSCOPIC APPENDECTOMY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN) 385
TABLE 54 LAPAROSCOPIC HERNIA REPAIR GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN) 387
TABLE 55 HAND ASSISTED LAPAROSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN) 389
TABLE 56 OTHER ENDOSCOPY APPLICATIONS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN) 394
TABLE 57 ENDOSCOPY DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS
(2020-2028) ($MN) 397
TABLE 58 ENDOSCOPES GLOBAL MARKET REVENUE, BY PRODUCTS
(2020-2028) ($MN) 401
TABLE 59 ENDOSCOPES GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 403
TABLE 60 RIGID ENDOSCOPES GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 406
TABLE 61 FLEXIBLE ENDOSCOPES GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 409
TABLE 62 ROBOT-ASSISTED ENDOSCOPES, AND AI ENHANCED ENDOSCOPES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN) 420
TABLE 63 CAPSULE ENDOSCOPES GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 425
TABLE 64 ENDOSCOPIC INSTRUMENTS GLOBAL MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN) 428
TABLE 65 ENDOSCOPIC INSTRUMENTS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN) 430
TABLE 66 ENDOSCOPIC CAMERAS GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 434
TABLE 67 DIGITAL DOCUMENTATION SYSTEMS GLOBAL MARKET REVENUE,
BY REGION (2020-2028) ($MN) 437
TABLE 68 LIGHT SOURCES GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 441
TABLE 69 MONITORS, AND DISPLAY SYSTEMS GLOBAL MARKET REVENUE,
BY REGION (2020-2028) ($MN) 444
TABLE 70 VIDEO CONVERTERS, AND PROCESSORS GLOBAL MARKET REVENUE,
BY REGION (2020-2028) ($MN) 447
TABLE 71 FLUID MANAGEMENT SYSTEMS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN) 449
TABLE 72 OTHER ENDOSCOPIC INSTRUMENTS GLOBAL MARKET REVENUE,
BY REGION (2020-2028) ($MN) 454
TABLE 73 ENDOSCOPIC ACCESSORIES GLOBAL MARKET REVENUE, BY PRODUCT (2020-2028) ($MN) 456
TABLE 74 ENDOSCOPIC ACCESSORIES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN) 458
TABLE 75 BIOPSY FORCEPS GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 462
TABLE 76 GRASPERS AND RETRACTORS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN) 466
TABLE 77 SNARES GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 470
TABLE 78 TROCARS GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 474
TABLE 79 SURGICAL DISSECTORS GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 476
TABLE 80 OTHER ENDOSCOPIC ACCESSORIES GLOBAL MARKET REVENUE,
BY REGION (2020-2028) ($MN) 481
TABLE 81 ENDOSCOPY DEVICES GLOBAL MARKET REVENUE, BY END-USERS
(2020-2028) ($MN) 485
TABLE 82 HOSPITALS GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 490
TABLE 83 ENDOSCOPY AMBULATORY SURGERY CENTERS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN) 493
TABLE 84 ENDOSCOPY DIAGNOSTIC CENTRES GLOBAL MARKET REVENUE,
BY REGION (2020-2028) ($MN) 495
TABLE 85 OTHER END-USERS GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 498
TABLE 86 GLOBAL ARTHROSCOPY PROCEDURAL VOLUME, BY REGION
(2020-2028) (NO’S) (MN) 500
TABLE 87 GLOBAL GASTROINTESTINAL ENDOSCOPY PROCEDURAL VOLUME,
BY REGION (2020-2028) (NO’S) (MN) 501
TABLE 88 GLOBAL COLONOSCOPY PROCEDURAL VOLUME, BY REGION
(2020-2028)(NO’S) (MN) 502
TABLE 89 GLOBAL UROLOGY ENDOSCOPY PROCEDURAL VOLUME, BY REGION
(2020-2028) (NO’S) (MN) 503
TABLE 90 GLOBAL LAPAROSCOPY ROCEDURAL VOLUME, BY REGION
(2020-2028) (NO’S) (MN) 505
TABLE 91 GLOBAL ENT ENDOSCOPY PROCEDURAL VOLUME, BY REGION
(2020-2028) (NO’S) (MN) 506
TABLE 92 GLOBAL PULMONARY ENDOSCOPY ROCEDURAL VOLUME, BY REGION
(2020-2028) (NO’S) (MN) 507
TABLE 93 GLOBAL NEUROENDOSCOPY PROCEDURAL VOLUME, BY REGION
(2020-2028) (NO’S) (MN) 508
TABLE 94 ENDOSCOPY DEVICES GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 513
TABLE 95 NORTH AMERICA ENDOSCOPY DEVICES MARKET REVENUE, BY COUNTRY, (2020-2028) ($MN) 522
TABLE 96 NORTH AMERICA ENDOSCOPY DEVICES MARKET REVENUE,
BY APPLICATIONS (2020-2028) ($MN) 524
TABLE 97 NORTH AMERICA ARTHROSCOPY MARKET REVENUE, BY ANATOMY
(2020-2028) ($MN) 526
TABLE 98 NORTH AMERICA LAPAROSCOPY MARKET REVENUE, BY ANATOMY
(2020-2028) ($MN) 528
TABLE 99 NORTH AMERICA PULMONARY ENDOSCOPY MARKET REVENUE,
BY ANATOMY (2020-2028) ($MN) 530
TABLE 100 NORTH AMERICA ENT ENDOSCOPY MARKET REVENUE, BY ANATOMY
(2020-2028) ($MN) 532
TABLE 101 NORTH AMERICA GASTROINTESTINAL ENDOSCOPY MARKET REVENUE,
BY ANATOMY (2020-2028) ($MN) 534
TABLE 102 NORTH AMERICA GYNECOLOGY ENDOSCOPY MARKET REVENUE,
BY ANATOMY (2020-2028) ($MN) 536
TABLE 103 NORTH AMERICA NEUROENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN) 538
TABLE 104 NORTH AMERICA UROLOGICAL ENDOSCOPY MARKET REVENUE,
BY ANATOMY (2020-2028) ($MN) 540
TABLE 105 NORTH AMERICA ENDOSCOPY DEVICES MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN) 542
TABLE 106 NORTH AMERICA ENDOSCOPES MARKET REVENUE, BY PRODUCT
(2020-2028) ($MN) 544
TABLE 107 NORTH AMERICA ENDOSCOPIC INSTRUMENTS MARKET REVENUE,
BY PRODUCT (2020-2028) ($MN) 546
TABLE 108 NORTH AMERICA ENDOSCOPY ACCESSORIES MARKET REVENUE,
BY PRODUCT (2020-2028) ($MN) 548
TABLE 109 NORTH AMERICA ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2020-2028) ($MN) 550
TABLE 110 EUROPE ENDOSCOPY DEVICES MARKET REVENUE, BY COUNTRY,
(2020-2028) ($MN) 583
TABLE 111 EUROPE ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATIONS (2020-2028) ($MN) 585
TABLE 112 EUROPE ARTHROSCOPY MARKET REVENUE, BY ANATOMY
(2020-2028) ($MN) 587
TABLE 113 EUROPE LAPAROSCOPY MARKET REVENUE, BY ANATOMY
(2020-2028) ($MN) 589
TABLE 114 EUROPE PULMONARY ENDOSCOPY MARKET REVENUE, BY ANATOMY
(2020-2028) ($MN) 591
TABLE 115 EUROPE ENT ENDOSCOPY MARKET REVENUE, BY ANATOMY
(2020-2028) ($MN) 593
TABLE 116 EUROPE UROLOGICAL ENDOSCOPY MARKET REVENUE, BY ANATOMY
(2020-2028) ($MN) 595
TABLE 117 EUROPE NEUROENDOSCOPY MARKET REVENUE, BY ANATOMY
(2020-2028) ($MN) 597
TABLE 118 EUROPE GASTROINTESTINAL ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN) 599
TABLE 119 EUROPE GYNECOLOGY ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN) 601
TABLE 120 EUROPE ENDOSCOPY DEVICES MARKET REVENUE, BY PRODUCTS
(2020-2028) ($MN) 603
TABLE 121 EUROPE ENDOSCOPES MARKET REVENUE, BY PRODUCTS
(2020-2028) ($MN) 605
TABLE 122 EUROPE ENDOSCOPIC INSTRUMENTS MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN) 607
TABLE 123 EUROPE ENDOSCOPIC ACCESSORIES MARKET REVENUE, BY PRODUCT (2020-2028) ($MN) 609
TABLE 124 EUROPE ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS
(2020-2028) ($MN) 611
TABLE 125 ASIA-PACIFIC ENDOSCOPY DEVICES MARKET REVENUE, BY COUNTRY (2020-2028) ($MN) 651
TABLE 126 ASIA-PACIFIC ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATIONS (2020-2028) ($MN) 653
TABLE 127 ASIA-PACIFIC ARTHROSCOPY MARKET REVENUE, BY ANATOMY
(2020-2028) ($MN) 655
TABLE 128 ASIA-PACIFIC LAPAROSCOPY MARKET REVENUE, BY ANATOMY
(2020-2028) ($MN) 657
TABLE 129 ASIA-PACIFIC PULMONARY ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN) 659
TABLE 130 ASIA-PACIFIC ENT ENDOSCOPY MARKET REVENUE, BY ANATOMY
(2020-2028) ($MN) 661
TABLE 131 ASIA-PACIFIC GASTROINTESTINAL ENDOSCOPY MARKET REVENUE,
BY ANATOMY (2020-2028) ($MN) 663
TABLE 132 ASIA-PACIFIC GYNECOLOGY ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN) 665
TABLE 133 ASIA-PACIFIC NEUROENDOSCOPY MARKET REVENUE, BY ANATOMY
(2020-2028) ($MN) 667
TABLE 134 ASIA-PACIFIC UROLOGICAL ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN) 669
TABLE 135 ASIA-PACIFIC ENDOSCOPY DEVICES MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN) 671
TABLE 136 ASIA-PACIFIC ENDOSCOPES MARKET REVENUE, BY PRODUCTS
(2020-2028) ($MN) 673
TABLE 137 ASIA-PACIFIC ENDOSCOPIC INSTRUMENTS MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN) 675
TABLE 138 ASIA-PACIFIC ENDOSCOPY ACCESSORIES MARKET REVENUE, BY PRODUCT (2020-2028) ($MN) 677
TABLE 139 ASIA-PACIFIC ENDOSCOPY MARKET REVENUE, BY END-USERS
(2020-2028) ($MN) 679
TABLE 140 ROW ENDOSCOPY DEVICES MARKET REVENUE, BY COUNTRY
(2020-2028) ($MN) 724
TABLE 141 ROW ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATIONS
(2020-2028) ($MN) 726
TABLE 142 ROW ARTHROSCOPY MARKET REVENUE, BY ANATOMY
(2020-2028) ($MN) 728
TABLE 143 ROW LAPAROSCOPY MARKET REVENUE, BY ANATOMY
(2020-2028) ($MN) 730
TABLE 144 ROW PULMONARY ENDOSCOPY MARKET REVENUE, BY ANATOMY
(2020-2028) ($MN) 732
TABLE 145 ROW ENT ENDOSCOPY MARKET REVENUE, BY ANATOMY
(2020-2028) ($MN) 734
TABLE 146 ROW UROLOGICAL ENDOSCOPY MARKET REVENUE, BY ANATOMY
(2020-2028) ($MN) 736
TABLE 147 ROW NEUROENDOSCOPY MARKET REVENUE, BY ANATOMY
(2020-2028) ($MN) 738
TABLE 148 ROW GASTROINTESTINAL ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN) 740
TABLE 149 ROW GYNECOLOGY ENDOSCOPY MARKET REVENUE, BY ANATOMY
(2020-2028) ($MN) 742
TABLE 150 ROW ENDOSCOPY DEVICES MARKET REVENUE, BY PRODUCTS
(2020-2028) ($MN) 744
TABLE 151 ROW ENDOSCOPES MARKET REVENUE, BY PRODUCTS
(2020-2028) ($MN) 746
TABLE 152 ROW ENDOSCOPIC INSTRUMENTS MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN) 748
TABLE 153 ROW ENDOSCOPY ACCESSORIES MARKET REVENUE, BY PRODUCT
(2020-2028) ($MN) 750
TABLE 154 ROW ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS
(2020-2028) ($MN) 752
TABLE 155 PRODUCT APPROVALS (2020-2021) 780
TABLE 156 PRODUCT LAUNCH (2020-2021) 783
TABLE 157 ACQUISITIONS (2020-2021) 786
TABLE 158 COLLABORATIONS, (2020-2021) 788
TABLE 159 OTHER DEVELOPMENTS (2020-2021) 789
TABLE 160 B. BRAUN MELSUNGEN AG: TOTAL REVENUE, AND R&D EXPENSES
(2018-2020) ($MN) 801
TABLE 161 B. BRAUN MELSUNGEN AG: TOTAL REVENUE BY SEGMENTS
(2018-2020) ($MN) 802
TABLE 162 B. BRAUN MELSUNGEN AG: TOTAL REVENUE, BY GEOGRAPHY,
(2018-2020) ($MN) 803
TABLE 163 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2019-2021) (Q2) ($MN) 810
TABLE 164 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE BY SEGMENTS, (2019-2021) (Q2) ($MN) 811
TABLE 165 BOSTON SCIENTIFIC CORPORATION: MEDSURG TOTAL REVENUE, BY SUB-SEGMENTS, (2019-2021) (Q2) ($MN) 812
TABLE 166 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE BY GEOGRAPHY (2019-2021) (Q2) ($MN) 813
TABLE 167 FUJIFILM HOLDINGS CORPORATION: TOTAL REVENUE, AND R&D EXPENSES (2019-2021) (Q1) ($MN) 820
TABLE 168 FUJIFILM HOLDINGS CORPORATION: TOTAL REVENUE, BY SEGMENTS (2019-2021) (Q1) ($MN) 821
TABLE 169 FUJIFILM HOLDINGS CORPORATION: TOTAL REVENUE, BY REGION
(2019-2021) (Q1) ($MN) 822
TABLE 170 HOYA CORPORATION: TOTAL REVENUE, AND R&D EXPENSES,
(2019-2021) (Q1) ($MN) 832
TABLE 171 HOYA CORPORATION: TOTAL REVENUE, BY SEGMENTS,
(2019-2021) (Q1) ($MN) 832
TABLE 172 HOYA CORPORATION: LIFE CARE SEGMENT TOTAL REVENUE,
BY SUB-SEGMENTS, (2019-2021) (Q1) ($MN) 833
TABLE 173 HOYA CORPORATION: TOTAL REVENUE, BY GEOGRAPHY,
(2019-2021) (Q1) ($MN) 834
TABLE 174 JOHNSON & JOHNSON: TOTAL REVENUE, AND R&D EXPENSES
(2019-2021) (Q2) ($MN) 843
TABLE 175 JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENTS
(2019-2021) (Q2) ($MN) 844
TABLE 176 JOHNSON & JOHNSON: MEDICAL DEVICES REVENUE, BY SUB-SEGMENTS (2019-2021) (Q2) ($MN) 845
TABLE 177 JOHNSON & JOHNSON: TOTAL REVENUE, BY GEOGRAPHY
(2019-2021) (Q2) ($MN) 846
TABLE 178 MEDTRONIC PLC: TOTAL REVENUE, AND R&D EXPENSES
(2019-2021) (Q1) ($MN) 864
TABLE 179 MEDTRONIC PLC : TOTAL REVENUE, BY SEGMENTS
(2019-2021) (Q1) ($MN) 865
TABLE 180 MEDTRONIC PLC : MEDICAL SURGICAL REVENUE, BY SUB-SEGMENTS (2019-2021) (Q1) ($MN) 866
TABLE 181 MEDTRONIC, PLC: NEUROSCIENCE REVENUE, BY SUB-SEGMENTS
(2019-2021) (Q1) ($MN) 867
TABLE 182 MEDTRONIC PLC : TOTAL REVENUE, BY GEOGRAPHY
(2019-2021) (Q1) ($MN) 868
TABLE 183 OLYMPUS CORPORATION: TOTAL REVENUE, AND R&D EXPENSES,
(2019-2021) (Q1) ($MN) 875
TABLE 184 OLYMPUS CORPORATION: TOTAL REVENUE, BY SEGMENTS,
(2019-2021) (Q1) ($MN) 876
TABLE 185 OLYMPUS CORPORATION: TOTAL REVENUE, BY GEOGRAPHY,
(2019-2021) (Q1) ($MN) 877
TABLE 186 STRYKER CORPORATION: TOTAL REVENUE, AND R&D EXPENSES,
(2019-2021) (Q2) ($MN) 895
TABLE 187 STRYKER CORPORATION: TOTAL REVENUE, BY SEGMENTS,
(2019-2021) (Q2) ($MN) 896
TABLE 188 STRYKER CORPORATION: MEDSURG TOTAL REVENUE, BY SUB-SEGMENTS, (2019-2021) (Q2) ($MN) 897
TABLE 189 STRYKER CORPORATION: TOTAL REVENUE, BY GEOGRAPHY,
(2019-2021) (Q2) ($MN) 898

LIST OF FIGURES

FIGURE 1 ENDOSCOPY DEVICES GLOBAL MARKET REVENUE, AND MARKET SHARE,
BY REGION (2020-2028) ($MN) 43
FIGURE 2 ENDOSCOPY DEVICES GLOBAL MARKET: RESEARCH APPROACH 58
FIGURE 3 ENDOSCOPY DEVICES GLOBAL MARKET:
TOP-DOWN AND BOTTOM-UP APPROACH 59
FIGURE 4 ENDOSCOPY DEVICES GLOBAL MARKET: FORECASTING MODEL 60
FIGURE 5 ENDOSCOPY DEVICES MARKET: MARKET BREAKDOWN & DATA TRIANGULATION 61
FIGURE 6 ENDOSCOPY DEVICES GLOBAL MARKET: MARKET SEGMENTATION 69
FIGURE 7 ENDOSCOPY DEVICES GLOBAL MARKET: APPLICATION MARKET SEGMENTATION 70
FIGURE 8 MARKET DYNAMICS 71
FIGURE 9 ENDOSCOPY DEVICES CLINICAL TRIAL ANALYSIS 138
FIGURE 10 ENDOSCOPY DEVICES MARKET: PATENT FILING BY MAJOR PLAYERS
(2017-2021) 148
FIGURE 11 ENDOSCOPY DEVICES MARKET: PORTER’S ANALYSIS 163
FIGURE 12 ENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS
(2021) (%) 189
FIGURE 13 ARTHROSCOPY DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS
(2021) (%) 194
FIGURE 14 PULMONARY ENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS (2021) (%) 197
FIGURE 15 LAPAROSCOPY DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS
(2021) (%) 201
FIGURE 16 UROLOGICAL ENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS (2021) (%) 204
FIGURE 17 ENT ENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS (2021) (%) 207
FIGURE 18 GI ENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS
(2021) (%) 210
FIGURE 19 GYNECOLOGY ENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS (2021) (%) 214
FIGURE 20 NEUROENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS (2021) (%) 217
FIGURE 21 ENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY APPLICATION
(2021) (CAGR) (%) 236
FIGURE 22 ARTHROSCOPY DEVICES GLOBAL MARKET SHARE, BY ANATOMY
(2021 VS 2028) (%) 240
FIGURE 23 HIP ARTHROSCOPY GLOBAL MARKET SHARE, BY REGION
(2021 VS 2028) (%) 258
FIGURE 24 PULMONARY ENDOSCOPY GLOBAL MARKET SHARE, BY ANATOMY
(2021 VS 2028) (%) 264
FIGURE 25 ENT ENDOSCOPY GLOBAL MARKET SHARE, BY ANATOMY,
(2021 VS 2028) (%) 279
FIGURE 26 NASAL ENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY REGION
(2021 VS 2028) (%) 284
FIGURE 27 GASTROINTESTINAL ENDOSCOPY GLOBAL MARKET SHARE, BY ANATOMY (2021 VS 2028) (%) 298
FIGURE 28 ENTEROSCOPY GLOBAL MARKET SHARE, BY REGION
(2021 VS 2028) (%) 308
FIGURE 29 COLONOSCOPY GLOBAL MARKET SHARE, BY REGION
(2021 VS 2028) (%) 313
FIGURE 30 SIGMOIDOSCOPY GLOBAL MARKET SHARE, BY REGION
(2021 VS 2028) (%) 317
FIGURE 31 CHOLANGIOPANCREATOSCOPY GLOBAL MARKET SHARE, BY REGION
(2021 VS 2028) (%) 324
FIGURE 32 GYNECOLOGY/OBSTETRICSENDOSCOPY GLOBAL MARKET SHARE,
BY ANATOMY (2021 VS 2028) (%) 328
FIGURE 33 HYSTEROSCOPY GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%) 333
FIGURE 34 NEUROENDOSCOPY GLOBAL MARKET SHARE, BY ANATOMY (2021 VS 2028) (%) 345
FIGURE 35 UROLOGICAL ENDOSCOPY GLOBAL MARKET SHARE, BY ANATOMY
(2021 VS 2028) (%) 360
FIGURE 36 URETEROSCOPY GLOBAL MARKET SHARE, BY REGION
(2021 VS 2028) (%) 370
FIGURE 37 LAPAROSCOPY GLOBAL MARKET SHARE, BY ANATOMY
(2021 VS 2028) (%) 377
FIGURE 38 ENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY PRODUCTS
(2021 VS 2028) (%) 398
FIGURE 39 ENDOSCOPES GLOBAL MARKET SHARE, BY PRODUCTS
(2021 VS 2028) (%) 402
FIGURE 40 FLEXIBLE ENDOSCOPES GLOBAL MARKET SHARE, BY REGION
(2021 VS 2028) (%) 410
FIGURE 41 ENDOSCOPIC INSTRUMENTS GLOBAL MARKET SHARE, BY PRODUCT,
(2021 VS 2028) (%) 429
FIGURE 42 ENDOSCOPIC INSTRUMENTS GLOBAL MARKET REVENUE, BY REGION
(2021 VS 2028) (%) 431
FIGURE 43 MONITORS, AND DISPLAY UNITS GLOBAL MARKET REVENUE, BY REGION (2021 VS 2028) (%) 445
FIGURE 44 ENDOSCOPY ACCESSORIES GLOBAL MARKET SHARE, BY PRODUCTS
(2021 VS 2028) (%) 457
FIGURE 45 ENDOSCOPY ACCESSORIES GLOBAL MARKET SHARE, BY REGION
(2021 VS 2028) (%) 459
FIGURE 46 BIOPSY FORCEPS GLOBAL MARKET SHARE, BY REGION
(2021 VS 2028) (%) 463
FIGURE 47 GRASPERS, AND RETRACTORS GLOBAL MARKET SHARE, BY REGION
(2021 VS 2028) (%) 467
FIGURE 48 SNARES GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%) 471
FIGURE 49 OTHER ENDOSCOPIC ACCESSORIES GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%) 482
FIGURE 50 ENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY END-USERS
(2021 VS 2028) (%) 486
FIGURE 51 GLOBAL ENDOSCOPY PROCEDURAL VOLUME (NO’S) (MN) 509
FIGURE 52 GLOBAL ENDOSCOPY PROCEDURE VOLUME,
(2021 VS 2028) NO’S (MN) 510
FIGURE 53 ENDOSCOPY DEVICES GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 514
FIGURE 54 ENDOSCOPY DEVICES GLOBAL MARKET REVENUE, BY REGION & COUNTRY (2021) ($MN) 515
FIGURE 55 NORTH AMERICA ENDOSCOPY DEVICES MARKET SHARE, BY COUNTRY, (2021 VS 2028) (%) 523
FIGURE 56 NORTH AMERICA ENDOSCOPY DEVICES MARKET SHARE, BY APPLICATION (2021) & CAGR (%) 525
FIGURE 57 NORTH AMERICA ARTHROSCOPY MARKET SHARE, BY ANATOMY
(2021 VS 2028) (%) 527
FIGURE 58 NORTH AMERICA LAPAROSCOPY MARKET SHARE, BY ANATOMY
(2021 VS 2028) (%) 529
FIGURE 59 NORTH AMERICA PULMONARY ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%) 531
FIGURE 60 NORTH AMERICA ENT ENDOSCOPY MARKET SHARE, BY ANATOMY
(2021 VS 2028) (%) 533
FIGURE 61 NORTH AMERICA GASTROINTESTINAL ENDOSCOPY MARKET SHARE,
BY ANATOMY (2021 VS 2028) (%) 535
FIGURE 62 NORTH AMERICA GYNECOLOGY ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%) 537
FIGURE 63 NORTH AMERICA NEUROENDOSCOPY MARKET SHARE, BY ANATOMY
(2021 VS 2028) (%) 539
FIGURE 64 NORTH AMERICA UROLOGICAL ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%) 541
FIGURE 65 NORTH AMERICA ENDOSCOPY DEVICES MARKET SHARE, BY PRODUCT (2021 VS 2028) (%) 543
FIGURE 66 NORTH AMERICA ENDOSCOPES MARKET SHARE, BY PRODUCT
(2021 VS 2028) (%) 545
FIGURE 67 NORTH AMERICA ENDOSCOPIC INSTRUMENTS MARKET SHARE,
BY PRODUCT (2021 VS 2028) (%) 547
FIGURE 68 NORTH AMERICA PULMONARY ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%) 549
FIGURE 69 NORTH AMERICA ENDOSCOPY DEVICES MARKET SHARE, BY END-USERS (2021 VS 2028) (%) 551
FIGURE 70 NORTH AMERICA ENDOSCOPY PROCEDURE VOLUME,
(2021 VS 2028), NO’S (MN) 552
FIGURE 71 U.S. ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION
(2021 VS 2028) ($MN) 561
FIGURE 72 U.S. ENDOSCOPY DEVICES, AND ENDOSCOPES MARKET REVENUE,
BY PRODUCTS (2021 VS 2028) ($MN) 562
FIGURE 73 U.S ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS
(2021 VS 2028) ($MN) 563
FIGURE 74 REST OF NORTH AMERICA ENDOSCOPY DEVICES MARKET REVENUE,
BY APPLICATION (2021 VS 2028) ($MN) 573
FIGURE 75 REST OF NORTH AMERICA ENDOSCOPY DEVICES, AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2021 VS 2028) ($MN) 574
FIGURE 76 REST OF NORTH AMERICA ENDOSCOPY DEVICES MARKET REVENUE,
BY END-USERS (2021 VS 2028) ($MN) 575
FIGURE 77 EUROPE ENDOSCOPY DEVICES MARKET SHARE, BY COUNTRY,
(2021 VS 2028) (%) 584
FIGURE 78 EUROPE ENDOSCOPY DEVICES MARKET SHARE, BY APPLICATION
(2021) (CAGR) (%) 586
FIGURE 79 EUROPE ARTHROSCOPY MARKET SHARE, BY ANATOMY
(2021 VS 2028) (%) 588
FIGURE 80 EUROPE LAPAROSCOPY MARKET SHARE, BY ANATOMY
(2021 VS 2028) (%) 590
FIGURE 81 EUROPE PULMONARY ENDOSCOPY MARKET SHARE, BY ANATOMY
(2021 VS 2028) (%) 592
FIGURE 82 EUROPE ENT ENDOSCOPY MARKET SHARE, BY ANATOMY
(2021 VS 2028) (%) 594
FIGURE 83 EUROPE UROLOGICAL ENDOSCOPY MARKET SHARE BY ANATOMY
(2021 VS 2028) (%) 596
FIGURE 84 EUROPE NEUROENDOSCOPY MARKET SHARE, BY ANATOMY
(2021 VS 2028) (%) 598
FIGURE 85 EUROPE GASTROINTESTINAL ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%) 600
FIGURE 86 EUROPE GYNECOLOGY ENDOSCOPY MARKET SHARE, BY ANATOMY
(2021 VS 2028) (%) 602
FIGURE 87 EUROPE ENDOSCOPY DEVICES MARKET BY PRODUCTS,
(2021 VS 2028) (%) 604
FIGURE 88 EUROPE ENDOSCOPES MARKET SHARE, BY PRODUCTS
(2021 VS 2028) (%) 606
FIGURE 89 EUROPE ENDOSCOPY INSTRUMENTS MARKET SHARE, BY PRODUCTS
(2021 VS 2028) (%) 608
FIGURE 90 EUROPE ENDOSCOPIC ACCESSORIES MARKET SHARE, BY PRODUCTS
(2021 VS 2028) (%) 610
FIGURE 91 EUROPE ENDOSCOPY DEVICES MARKET SHARE, BY END-USERS
(2021 VS 2028) (%) 612
FIGURE 92 EUROPE ENDOSCOPY PROCEDURE VOLUME,
(2021 VS 2028) NO’S, (MN) 613
FIGURE 93 GERMANY ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION (2021 VS 2028) ($MN) 620
FIGURE 94 GERMANY ENDOSCOPY DEVICES, AND ENDOSCOPES MARKET REVENUE,
BY PRODUCTS (2021 VS 2028) ($MN) 621
FIGURE 95 GERMANY ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2021 VS 2028) ($MN) 622
FIGURE 96 FRANCE ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION
(2021 VS 2028) ($MN) 626
FIGURE 97 FRANCE ENDOSCOPY DEVICES, AND ENDOSCOPES MARKET REVENUE,
BY PRODUCTS (2021 VS 2028) ($MN) 627
FIGURE 98 FRANCE ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS
(2021 VS 2028) ($MN) 628
FIGURE 99 U.K. ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION
(2021 VS 2028) ($MN) 634
FIGURE 100 U.K. ENDOSCOPY DEVICES, AND ENDOSCOPES MARKET REVENUE,
BY PRODUCTS (2021 VS 2028) ($MN) 635
FIGURE 101 U.K. ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS
(2021 VS 2028) ($MN) 636
FIGURE 102 REST OF EUROPE ENDOSCOPY DEVICES MARKET REVENUE,
BY APPLICATION (2021 VS 2028) ($MN) 642
FIGURE 103 REST OF EUROPE ENDOSCOPY DEVICES, AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2021 VS 2028) ($MN) 643
FIGURE 104 REST OF EUROPE ENDOSCOPY DEVICES MARKET REVENUE,
BY END-USERS (2021 VS 2028) ($MN) 644
FIGURE 105 ASIA PACIFIC ENDOSCOPY DEVICES MARKET SHARE, BY COUNTRY
(2021 VS 2028) (%) 652
FIGURE 106 ASIA-PACIFIC ENDOSCOPY DEVICES MARKET SHARE, BY APPLICATION (2021) (CAGR) (%) 654
FIGURE 107 ASIA-PACIFIC ARTHROSCOPY MARKET SHARE, BY ANATOMY
(2021 VS 2028) (%) 656
FIGURE 108 ASIA-PACIFIC LAPAROSCOPY MARKET SHARE, BY ANATOMY
(2021 VS 2028) (%) 658
FIGURE 109 ASIA-PACIFIC PULMONARY ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%) 660
FIGURE 110 ASIA-PACIFIC ENT ENDOSCOPY MARKETSHARE, BY ANATOMY
(2021 VS 2028) (%) 662
FIGURE 111 ASIA-PACIFIC GASTROINTESTINAL ENDOSCOPY MARKET SHARE,
BY ANATOMY (2021 VS 2028) (%) 664
FIGURE 112 ASIA-PACIFIC GYNECOLOGY ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%) 666
FIGURE 113 ASIA-PACIFIC NEUROENDOSCOPY MARKET SHARE, BY ANATOMY
(2021 VS 2028) (%) 668
FIGURE 114 ASIA-PACIFIC UROLOGICAL ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%) 670
FIGURE 115 ASIA-PACIFIC ENDOSCOPY DEVICES MARKET SHARE, BY PRODUCTS
(2021 VS 2028) (%) 672
FIGURE 116 ASIA-PACIFIC ENDOSCOPES MARKET SHARE, BY PRODUCTS
(2021 VS 2028) (%) 674
FIGURE 117 ASIA-PACIFIC ENDOSCOPIC INSTRUMENTS MARKET SHARE, BY PRODUCTS (2021 VS 2028) (%) 676
FIGURE 118 ASIA-PACIFIC ENDOSCOPY ACCESSORIES MARKET SHARE, BY PRODUCTS (2021 VS 2028) (%) 678
FIGURE 119 ASIA-PACIFIC ENDOSCOPY DEVICES MARKET SHARE, BY END-USERS (2021 VS 2028) (%) 680
FIGURE 120 ASIA PACIFIC ENDOSCOPY PROCEDURE VOLUME,
(2021 VS 2028) NO’S (MN) 681
FIGURE 121 JAPAN ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION
(2021 VS 2028) ($MN) 688
FIGURE 122 JAPAN ENDOSCOPY DEVICES, AND ENDOSCOPES MARKET REVENUE,
BY PRODUCTS (2021 VS 2028) ($MN) 689
FIGURE 123 JAPAN ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS
(2021 VS 2028) ($MN) 690
FIGURE 124 CHINA ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION
(2021 VS 2028) ($MN) 697
FIGURE 125 CHINA ENDOSCOPY DEVICES, AND ENDOSCOPES MARKET REVENUE,
BY PRODUCTS (2021 VS 2028) ($MN) 698
FIGURE 126 CHINA ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS
(2021 VS 2028) ($MN) 699
FIGURE 127 INDIA ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION
(2021 VS 2028) ($MN) 706
FIGURE 128 INDIA ENDOSCOPY DEVICES, AND ENDOSCOPES MARKET REVENUE,
BY PRODUCTS (2021 VS 2028) ($MN) 707
FIGURE 129 INDIA ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS
(2021 VS 2028) ($MN) 708
FIGURE 130 REST OF APAC ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION (2021 VS 2028) ($MN) 715
FIGURE 131 REST OF APAC ENDOSCOPY DEVICES, AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2021 VS 2028) ($MN) 716
FIGURE 132 REST OF APAC ENDOSCOPY MARKET REVENUE, BY END-USERS
(2021 VS 2028) ($MN) 717
FIGURE 133 ROW ENDOSCOPY DEVICES MARKET SHARE, BY COUNTRY
(2020 VS 2028) (%) 725
FIGURE 134 ROW ENDOSCOPY DEVICES MARKET SHARE, BY APPLICATIONS
(2021) (CAGR) (%) 727
FIGURE 135 ROW ARTHROSCOPY MARKET SHARE, BY ANATOMY
(2021 VS 2028) (%) 729
FIGURE 136 ROW LAPAROSCOPY MARKET SHARE, BY ANATOMY
(2021 VS 2028) (%) 731
FIGURE 137 ROW PULMONARY ENDOSCOPY MARKET SHARE, BY ANATOMY
(2021 VS 2028) (%) 733
FIGURE 138 ROW ENT ENDOSCOPY DEVICES MARKET SHARE, BY ANATOMY
(2021 VS 2028) (%) 735
FIGURE 139 ROW UROLOGICAL ENDOSCOPY MARKET SHARE, BY ANATOMY
(2021 VS 2028) (%) 737
FIGURE 140 ROW NEUROENDOSCOPY MARKET SHARE, BY ANATOMY
(2021 VS 2028) (%) 739
FIGURE 141 ROW GASTROINTESTINAL ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%) 741
FIGURE 142 ROW GYNECOLOGY ENDOSCOPY MARKET SHARE, BY ANATOMY
(2021 VS 2028) (%) 743
FIGURE 143 ROW ENDOSCOPY DEVICES MARKET SHARE, BY PRODUCTS
(2021 VS 2028) (%) 745
FIGURE 144 ROW ENDOSCOPES MARKET SHARE, BY PRODUCTS
(2021 VS 2028) (%) 747
FIGURE 145 ROW ENDOSCOPIC INSTRUMENTS MARKET SHARE, BY PRODUCT
(2021 VS 2028) (%) 749
FIGURE 146 ROW ENDOSCOPIC ACCESSORIES MARKET SHARE, BY PRODUCT
(2021 VS 2028) (%) 751
FIGURE 147 ROW ENDOSCOPY MARKET SHARE, BY END-USERS (2021 VS 2028) (%) 753
FIGURE 148 ROW ENDOSCOPY PROCEDURE VOLUME (2021 VS 2028), NO’S (MN) 754
FIGURE 149 BRAZIL ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION
(2021 VS 2028) ($MN) 759
FIGURE 150 BRAZIL ENDOSCOPY DEVICES, AND ENDOSCOPES MARKET REVENUE,
BY PRODUCTS (2021 VS 2028) ($MN) 760
FIGURE 151 BRAZIL ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS
(2021 VS 2028) ($MN) 761
FIGURE 152 REST OF LATAM ENDOSCOPY DEVICES MARKET REVENUE,
BY APPLICATION (2021 VS 2028) ($MN) 767
FIGURE 153 THE REST OF LATAM ENDOSCOPY DEVICES, AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2021 VS 2028) ($MN) 768
FIGURE 154 REST OF LATAM ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2021 VS 2028)($MN) 769
FIGURE 155 MIDDLE EAST & OTHERS ENDOSCOPY DEVICES MARKET REVENUE,
BY APPLICATION (2021 VS 2028) ($MN) 775
FIGURE 156 MIDDLE EAST & OTHERS ENDOSCOPY DEVICES, AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2021 VS 2028) ($MN) 776
FIGURE 157 MIDDLE EAST & OTHERS ENDOSCOPY MARKET REVENUE, BY END-USERS (2021 VS 2028) ($MN) 777
FIGURE 158 KEY GROWTH STRATEGIES, (2020-2021) 778
FIGURE 159 SWOT: ARTHREX, INC. 799
FIGURE 160 SWOT: B. BRAUN MELSUNGEN AG 808
FIGURE 161 SWOT: BOSTON SCIENTIFIC CORPORATION 818
FIGURE 162 SWOT: FUJIFILM HOLDINGS CORPORATION 830
FIGURE 163 SWOT: HOYA CORPORATION (PENTAX MEDICAL) 841
FIGURE 164 SWOT: JOHNSON & JOHNSON 851
FIGURE 165 SWOT: KARL STORZ SE & CO. KG 862
FIGURE 166 SWOT: MEDTRONIC PLC 873
FIGURE 167 SWOT: OLYMPUS CORPORATION 893
FIGURE 168 SWOT: STRYKER CORPORATION 903

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+